117 related articles for article (PubMed ID: 19928109)
21. Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.
Messiou C; Orton M; Ang JE; Collins DJ; Morgan VA; Mears D; Castellano I; Papadatos-Pastos D; Brunetto A; Tunariu N; Mann H; Tessier J; Young H; Ghiorghiu D; Marley S; Kaye SB; deBono JS; Leach MO; deSouza NM
Radiology; 2012 Nov; 265(2):426-36. PubMed ID: 22891356
[TBL] [Abstract][Full Text] [Related]
22. Distributed capillary adiabatic tissue homogeneity model in parametric multi-channel blind AIF estimation using DCE-MRI.
Kratochvíla J; Jiřík R; Bartoš M; Standara M; Starčuk Z; Taxt T
Magn Reson Med; 2016 Mar; 75(3):1355-65. PubMed ID: 25865576
[TBL] [Abstract][Full Text] [Related]
23. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
Jost G; Pietsch H; Grenacher L
Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
[TBL] [Abstract][Full Text] [Related]
24. Comparison of errors associated with single- and multi-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis.
Roberts C; Buckley DL; Parker GJ
Magn Reson Med; 2006 Sep; 56(3):611-9. PubMed ID: 16858671
[TBL] [Abstract][Full Text] [Related]
25. A parametric model of the brain vascular system for estimation of the arterial input function (AIF) at the tissue level.
Nejad-Davarani SP; Bagher-Ebadian H; Ewing JR; Noll DC; Mikkelsen T; Chopp M; Jiang Q
NMR Biomed; 2017 May; 30(5):. PubMed ID: 28211963
[TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
[TBL] [Abstract][Full Text] [Related]
27. Improved bolus arrival time and arterial input function estimation for tracer kinetic analysis in DCE-MRI.
Singh A; Rathore RK; Haris M; Verma SK; Husain N; Gupta RK
J Magn Reson Imaging; 2009 Jan; 29(1):166-76. PubMed ID: 19097111
[TBL] [Abstract][Full Text] [Related]
28. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI.
Cheng HL
J Magn Reson Imaging; 2008 Sep; 28(3):736-43. PubMed ID: 18777534
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis.
Bisdas S; Konstantinou GN; Lee PS; Thng CH; Wagenblast J; Baghi M; Koh TS
Phys Med Biol; 2007 Oct; 52(20):6181-96. PubMed ID: 17921579
[TBL] [Abstract][Full Text] [Related]
30. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
31. Dynamic contrast-enhanced CT of head and neck tumors: comparison of first-pass and permeability perfusion measurements using two different commercially available tracer kinetics models.
Bisdas S; Konstantinou G; Surlan-Popovic K; Khoshneviszadeh A; Baghi M; Vogl TJ; Koh TS; Mack MG
Acad Radiol; 2008 Dec; 15(12):1580-9. PubMed ID: 19000875
[TBL] [Abstract][Full Text] [Related]
32. An analysis of the pharmacokinetic parameter ratios in DCE-MRI using the reference region model.
Lee J; Platt S; Kent M; Zhao Q
Magn Reson Imaging; 2012 Jan; 30(1):26-35. PubMed ID: 22071409
[TBL] [Abstract][Full Text] [Related]
33. Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function.
Kim JH; Im GH; Yang J; Choi D; Lee WJ; Lee JH
NMR Biomed; 2012 Apr; 25(4):674-84. PubMed ID: 21954069
[TBL] [Abstract][Full Text] [Related]
34. Application of pharmacokinetics to computed tomography: injection rates and schemes: mono-, bi-, or multiphasic?
Krause W
Invest Radiol; 1996 Feb; 31(2):91-100. PubMed ID: 8750444
[TBL] [Abstract][Full Text] [Related]
35. Simulating the effect of input errors on the accuracy of Tofts' pharmacokinetic model parameters.
Lavini C
Magn Reson Imaging; 2015 Feb; 33(2):222-35. PubMed ID: 25308097
[TBL] [Abstract][Full Text] [Related]
36. A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: I. Simulations.
Schabel MC; Fluckiger JU; DiBella EV
Phys Med Biol; 2010 Aug; 55(16):4783-806. PubMed ID: 20679691
[TBL] [Abstract][Full Text] [Related]
37. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.
Yang C; Stadler WM; Karczmar GS; Milosevic M; Yeung I; Haider MA
Magn Reson Med; 2010 Jun; 63(6):1601-9. PubMed ID: 20512864
[TBL] [Abstract][Full Text] [Related]
38. An extended vascular model for less biased estimation of permeability parameters in DCE-T1 images.
Nejad-Davarani SP; Bagher-Ebadian H; Ewing JR; Noll DC; Mikkelsen T; Chopp M; Jiang Q
NMR Biomed; 2017 Jun; 30(6):. PubMed ID: 28211961
[TBL] [Abstract][Full Text] [Related]
39. DUSTER: dynamic contrast enhance up-sampled temporal resolution analysis method.
Liberman G; Louzoun Y; Artzi M; Nadav G; Ewing JR; Ben Bashat D
Magn Reson Imaging; 2016 May; 34(4):442-50. PubMed ID: 26708030
[TBL] [Abstract][Full Text] [Related]
40. Simulation of aortic peak enhancement on MDCT using a contrast material flow phantom: feasibility study.
Awai K; Hatcho A; Nakayama Y; Kusunoki S; Liu D; Hatemura M; Funama Y; Denbo M; Sato N; Yamashita Y
AJR Am J Roentgenol; 2006 Feb; 186(2):379-85. PubMed ID: 16423942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
